These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32773463)

  • 1. Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With Cirrhosis.
    Tapper EB; Zhao L; Nikirk S; Baki J; Parikh ND; Lok AS; Waljee AK
    Am J Gastroenterol; 2020 Dec; 115(12):2017-2025. PubMed ID: 32773463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Falls are common, morbid, and predictable in patients with cirrhosis.
    Tapper EB; Nikirk S; Parikh ND; Zhao L
    J Hepatol; 2021 Sep; 75(3):582-588. PubMed ID: 33887359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in frailty are associated with waitlist mortality in patients with cirrhosis.
    Lai JC; Dodge JL; Kappus MR; Dunn MA; Volk ML; Duarte-Rojo A; Ganger DR; Rahimi RS; McCulloch CE; Haugen CE; McAdams-DeMarco M; Ladner DP; Segev DL; Verna EC;
    J Hepatol; 2020 Sep; 73(3):575-581. PubMed ID: 32240717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Oral Health, Frailty, and Minimal Hepatic Encephalopathy in the Risk of Hospitalization: A Prospective Multi-Center Cohort of Outpatients With Cirrhosis.
    Bajaj JS; Lai JC; Tandon P; O'Leary JG; Wong F; Garcia-Tsao G; Vargas HE; Kamath PS; Biggins SW; Limon-Miro A; Shaw J; Mbachi C; Chew M; Golob Deeb J; Thacker LR; Reddy KR
    Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1864-1872.e2. PubMed ID: 36328307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence and outcome of postoperative hepatic encephalopathy in patients with cirrhosis.
    Saleh ZM; Solano QP; Louissaint J; Jepsen P; Tapper EB
    United European Gastroenterol J; 2021 Jul; 9(6):672-680. PubMed ID: 34102040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-S-100-beta is increased in patients with decompensated cirrhosis admitted to ICU.
    Weiss N; Tripon S; Mallet M; Imbert-Bismut F; Sakka M; Bonnefont-Rousselot D; Sultanik P; Mouri S; Rudler M; Thabut D
    J Intensive Med; 2024 Apr; 4(2):222-230. PubMed ID: 38681783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of 30-day mortality in patients diagnosed with hepatic encephalopathy on admission to the emergency department.
    Yuksek A; Acehan S; Satar S; Gulen M; Balcik M; Sevdimbas S; Ince C; Koca AN; Tas A
    Eur J Gastroenterol Hepatol; 2023 Dec; 35(12):1402-1409. PubMed ID: 37695624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sociodemographic characteristics, complications requiring hospital admission and causes of in-hospital death in patients with liver cirrhosis admitted at a district hospital in Ghana.
    Duah A; Agyei-Nkansah A; Osei-Poku F; Duah F; Addo BP
    PLoS One; 2021; 16(6):e0253759. PubMed ID: 34166471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of NOD2 risk variants on hepatic encephalopathy and association with inflammation, bacterial translocation and immune activation.
    Ripoll C; Greinert R; Reuken P; Reichert MC; Weber SN; Hupfer Y; Staltner R; Meier Clinien M; Lammert F; Bruns T; Zipprich A
    Liver Int; 2023 Aug; 43(8):1793-1802. PubMed ID: 37249050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic encephalopathy impacts the predictive value of the Fried Frailty Index.
    Tapper EB; Konerman M; Murphy S; Sonnenday CJ
    Am J Transplant; 2018 Oct; 18(10):2566-2570. PubMed ID: 30019835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis.
    Tandon P; Reddy KR; O'Leary JG; Garcia-Tsao G; Abraldes JG; Wong F; Biggins SW; Maliakkal B; Fallon MB; Subramanian RM; Thuluvath P; Kamath PS; Thacker LR; Bajaj JS;
    Hepatology; 2017 Jan; 65(1):217-224. PubMed ID: 27775842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic Encephalopathy in Cirrhotic Patients With Bacterial Infections: Frequency, Clinical Characteristics, and Prognostic Relevance.
    Guimarães L; Piedade J; Duarte J; Baldin C; Victor L; Costa B; Veiga Z; Alcântara C; Fernandes F; Pereira G
    J Clin Exp Hepatol; 2023; 13(4):559-567. PubMed ID: 37440943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting hepatic encephalopathy in patients with cirrhosis: A UK population-based study and validation of risk scores.
    Jones BI; Jenkins CA; Murphy D; Orr J; Yeoman A; Hubbuck ER; Heywood BR; Currie CJ
    Hepatol Commun; 2023 Nov; 7(11):. PubMed ID: 37930150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of and Risk Factors for Hepatic Encephalopathy in a Population-Based Cohort of Americans With Cirrhosis.
    Tapper EB; Henderson JB; Parikh ND; Ioannou GN; Lok AS
    Hepatol Commun; 2019 Nov; 3(11):1510-1519. PubMed ID: 31701074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Free Triiodothyronine, Gamma-Glutamyl Transpeptidase and Spontaneous Bacterial Peritonitis Index: A Novel Model for Predicting 1-Year Mortality in Patients with HBV-Related Hepatic Encephalopathy.
    Lin L; Huang ZY; Liu K; Tong XC; Zhang ZX; Xue Y
    Hepat Med; 2024; 16():1-9. PubMed ID: 38283915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Gastroenterology Consultation on the Clinical Outcomes of Patients Admitted With Hepatic Encephalopathy.
    Dutta N; Kc M; Wang Q; Lim N
    Cureus; 2023 Jul; 15(7):e41610. PubMed ID: 37565113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional counseling improves mortality and prevents hepatic encephalopathy in patients with alcohol-associated liver disease.
    Hanai T; Nishimura K; Unome S; Miwa T; Nakahata Y; Imai K; Suetsugu A; Takai K; Shimizu M
    Hepatol Res; 2024 Apr; ():. PubMed ID: 38683882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-Reported Outcome Screens for Cognitive Dysfunction and Predicts Admissions in Cirrhosis.
    Thuluvath AJ; Kim M; Peipert J; Duarte-Rojo A; Huang A; Siddiqui O; Nizamuddin M; Dietch Z; Levitsky J; Ladner DP
    Transplant Proc; 2024; 56(6):1378-1384. PubMed ID: 39025730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medically Tailored Meals for Patients With Cirrhosis and Hepatic Encephalopathy: The BRAINFOOD Proof-of-concept Trial.
    Tapper EB; Saleh ZM; Nikirk S; Bajaj J; Chen X; Lok AS
    J Clin Exp Hepatol; 2024; 14(6):101439. PubMed ID: 38882178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cohort Profile: Shiraz Pediatric Liver Cirrhosis Cohort (SPLCCS).
    Motazedian N; Geramizadeh B; Dehghani SM; Azarpira N; Hossein Aghdaei M; Yaghobi R; Shamsaeefar A; Kazemi K; Karimi MH; Mirahmadizadeh A; Mashhadiagha A; Ataollahi M; Ilkhanipoor H; Basiratnia M; Nemati H; Ekramzadeh M; Sanaei Dashti A; Nikeghbalian S; Malekhosseini SA
    Arch Iran Med; 2023 Apr; 26(4):229-233. PubMed ID: 38301084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.